RHBDF2 and hepatocellular carcinoma: Similarly, high RHBDF2 expression in HCC patients was associated with a worse RFS in enriched natural killer T cells (P = 0.014), Th1 cells (P = 0.0067), Th2 cells (P = 0.035), mesenchymal stem cells (P = 7.6E‐05), macrophages (P = 0.00029) and regulatory T cells (P = 0.0037) (Fig. 8K–P).